<DOC>
	<DOCNO>NCT02139488</DOCNO>
	<brief_summary>To quantify motion base variation target volume primary tumor course chemoradiotherapy esophageal cancer patient , use information calculate appropriate PTV ( plan target volume ) margin accord margin recipe patient receive trimodality ( neoadjuvant chemoradiation surgery ) definitive chemoradiation order personalize radiation treatment , result either good target coverage reduction normal tissue radiation exposure .</brief_summary>
	<brief_title>Organ Motion Early Tumor Response Measurement</brief_title>
	<detailed_description>A single center prospective observational study perform esophageal cancer patient . This study register motion esophageal tumor , use 4D planning CT scan repeat 4D CBCT scanning . Motion fiducial marker insert esophageal wall , use surrogate tumor motion limit image quality CBCT scan . Patients planned trimodality treatment additionally image serial 4D Pet CT MRI week 0 ( start chemoradiotherapy ) , week 3 ( chemoradiotherapy ) week 10 ( prior surgery ) observe ( early ) sign tumor response . Patients plan definitive chemoradiation receive extra MRI imaging treatment inability correlate image pathological response .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>1 . Histologic evidence invasive adenocarcinoma squamous cell cancer esophagus 2 . Patient eligible trimodality treatment ( chemoradiotherapy surgery ) definitive chemoradiotherapy 3 . T3N0M0 T1‐4N1‐3M0 . Patients M1 disease solely basis supraclavicular metastasis junction tumor primary eligible . ( AJCC 7th edition , ) . 4. WHO performance status ≤2 ( WHO scale ) 5 . Clinically operable R0 resection opinion experience upper gastrointestinal thoracic surgeon patient plan trimodality 6 . Tumor localization least 2cm upper esophageal sphincter invade 5cm gastric cardia 7 . Age ≥ 18 year 8 . Written inform consent endoscopy EUS Exclusion criterion : 1 . Prior treatment thoracic surgery thoracic radiotherapy 2 . Pregnancy 3 . Severe cardiopulmonary restriction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Esophageal cancer</keyword>
	<keyword>Chemoradiation</keyword>
</DOC>